Ivermectin: A Multifaceted Drug of Nobel Prize-honoured Distinction with Indicated Efficacy Against a New Global Scourge, COVID-19

A. D. Santin, D. E. Scheim, P. A. McCullough, M. Yagisawa, T. J. Borody

In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world’s most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments. Reductions in deaths correlated with the extent of IVM distributions in all 25 states with p < 0.002. Sharp reductions in morbidity using IVM were also observed in two animal models, of SARS-CoV-2 and a related betacoronavirus. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains.

Latest articles

Miranda Castro Schüssler investigated the chemical make-up of human cells and found...
Craig Paardekooper An FOIA request by Judicial Watch led to the disclosure...
Dobrin Draganov et al. Ivermectin converts cold tumors hot and synergizes with...
Technocracy News Digital identity, digital twins, programmable central bank digital currency, a...
Aaron Kheriaty Unless we collectively decline to participate in this new social...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!